Annual report [Section 13 and 15(d), not S-K Item 405]

Segment Information (Tables)

v3.26.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Financial Information

    2025     2024  
   

Years Ended

December 31,

 
    2025     2024  
Research and development   $            
Clinical     705,645       5,796,196  
Chemistry, manufacturing and controls and nonclinical     349,645       454,913  
Personnel related     1,874,693       1,952,582  
Total research and development   $ 2,929,983     $ 8,203,691  
Selling, general and administrative                
Compliance     2,623,871       2,590,187  
Marketing     738,340       -  
Personnel related     1,481,404       1,719,364  
Total selling, general and administrative     4,843,615       4,309,551  
Interest income     215,041       225,781  
Net loss   $ (7,558,557 )     (12,287,461 )